Dr. Elias J. Jabbour     CML      Chronic Myeloid Leukemia    

Assistant Professor, Department of Leukemia,
Division of Cancer Medicine,
The University of Texas MD Anderson Cancer Center, Houston, TX

Curiculum Vitae ( Publications)

CML Update at ASH 2011 - Interview with Elias Jabbour, M.D.                VIDEO
January 27, 2012, OncUViewTV

Expert Insights: CML Updates From Summer 2011
August 17, 2011, Medscape education

Dr. Jabbour on Front-Line Treatments for CML                                               VIDEO
March 15, 2011, OncLiveTV

Dr. Jabbour on Second-Generation TKIs in CML                                  VIDEO
March 15, 2011, OncLiveTV

Discontinuation of imatinib may be possible in chronic myelogenous leukemia
March 4, 2011, Online Library

Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure
February 10, 2011, Journal Blood

Tyrosine Kinase Inhibitors in CML: Applying New Data to Practice -- An Expert Interview
With Dr. Elias J. Jabbour From ASH 2009
2009, Medscape Education